CVIR Endovascular (Mar 2022)

Treatment of massive hemoptysis after thoracic aortic aneurysm repair

  • Fumio Morimura,
  • Kohei Hamamoto,
  • Hiromi Edo,
  • Osamu Ishida,
  • Koji Tsustsumi,
  • Soichiro Tamada,
  • Hiroshi Kuwamura,
  • Yasuhiro Enjoji,
  • Yohsuke Suyama,
  • Hiroaki Sugiura,
  • Sadahiro Watanabe,
  • Ippei Ozaki,
  • Hiroshi Shinmoto

DOI
https://doi.org/10.1186/s42155-022-00293-3
Journal volume & issue
Vol. 5, no. 1
pp. 1 – 6

Abstract

Read online

Abstract Background Massive hemoptysis after thoracic aortic aneurysm (TAA) repair is a rare but potentially lethal condition. Endovascular management is a challenging treatment option due to the complexity of culprit vessel access. Case presentation An 81-year-old woman was referred to our hospital with massive hemoptysis. She had a history of graft replacement and thoracic endovascular aortic repair (TEVAR) for dissecting TAA. Computed tomography (CT) showed massive atelectasis with hematoma in the left lower lung lobe adjacent to the descending aortic aneurysm treated with TEVAR. Contrast-enhanced CT revealed a pseudoaneurysm and proliferation of abnormal vessels at the peripheral side of the left pulmonary ligament artery (PLA) in the atelectasis. The PLA continued to the right subscapular artery via a complex collateral pathway. Diagnostic angiography of the right subcapsular artery revealed a pseudoaneurysm and abnormal vessels at the peripheral side of the left PLA with a systemic-pulmonary artery shunt. Transcatheter arterial embolization (TAE) for the left PLA via the collateral pathway with N-butyl cyanoacrylate achieved complete embolization. The patient’s hemoptysis was controlled and she was discharged. Conclusions Here we presented a case of massive hemoptysis due to PLA disruption that occurred after TAA repair. TAE via a complex collateral pathway is a feasible and effective treatment for hemoptysis, even in patients who have undergone surgical or endovascular TAA repair.

Keywords